Search by Drug Name or NDC
NDC 46122-0701-65 GNP Pink Bismuth 262 mg/1 Details
GNP Pink Bismuth 262 mg/1
GNP Pink Bismuth is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Amerisource Bergen. The primary component is BISMUTH SUBSALICYLATE.
MedlinePlus Drug Summary
Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
Related Packages: 46122-0701-65Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bismuth Subsalicylate
Product Information
NDC | 46122-0701 |
---|---|
Product ID | 46122-701_f696a151-4c97-485b-b049-a2fc57620d3f |
Associated GPIs | 47300010000507 |
GCN Sequence Number | 002860 |
GCN Sequence Number Description | bismuth subsalicylate TAB CHEW 262 MG ORAL |
HIC3 | D6D |
HIC3 Description | ANTIDIARRHEALS |
GCN | 08420 |
HICL Sequence Number | 001246 |
HICL Sequence Number Description | BISMUTH SUBSALICYLATE |
Brand/Generic | Generic |
Proprietary Name | GNP Pink Bismuth |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bismuth subsalicylate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 262 |
Active Ingredient Units | mg/1 |
Substance Name | BISMUTH SUBSALICYLATE |
Labeler Name | Amerisource Bergen |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part335 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 46122-0701-65 (46122070165)
NDC Package Code | 46122-701-65 |
---|---|
Billing NDC | 46122070165 |
Package | 5 BLISTER PACK in 1 BOX (46122-701-65) / 6 TABLET, CHEWABLE in 1 BLISTER PACK |
Marketing Start Date | 2021-09-16 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.07853 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | GNP PINK BISMUTH 262 MG TB CHW |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL a6ed50d5-574f-4d6b-be48-e14659338993 Details
WARNINGS
Reye's Syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behaviour with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's Syndrome, a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are
- allergic to salicylates (including aspirin)
- taking other salicylate products
ASK A DOCTOR OR PHARMACIST BEFORE USE IF YOU ARE
STOP USE AND ASK DOCTOR IF
KEEP OUT OF REACH OF CHILDREN
DIRECTIONS
OTHER INFORMATION
INACTIVE INGREDIENTS
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
GNP PINK BISMUTH
bismuth subsalicylate tablet, chewable |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Amerisource Bergen (007914906) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Guardian Drug Company | 119210276 | MANUFACTURE(46122-701) |